USANA
July 22, 2025
SALT LAKE CITY, Utah - July 22, 2025
USANA Health Sciences reported second-quarter 2025 net sales of 236 million dollars, up 11 percent from 213 million dollars a year earlier, helped by its Hiya children's health business, which contributed 34 million dollars and ended the quarter with 200,400 active monthly subscribers. Net earnings slipped to 9.7 million dollars, or 0.52 dollars per diluted share, from 10.4 million dollars, or 0.54 dollars. Adjusted earnings were 0.74 dollars per share and adjusted EBITDA was 30 million dollars.
The core direct selling business continued to shrink, with active customers falling to 418,000 from 468,000. Asia Pacific sales fell 4 percent to 163 million dollars, including a 2 percent decline in Greater China to 113 million dollars, while the Americas and Europe fell 8 percent to 39 million dollars. Chief Executive Jim Brown said the company is rolling out an enhanced incentive offering for its sales force, has adopted the term Brand Partner for its sellers and will announce a simplified direct sales model and other changes during the third quarter.
USANA reiterated its 2025 outlook for net sales of 920 million dollars to 1.0 billion dollars and adjusted earnings of 2.35 to 3.00 dollars per share. The company repaid the 23 million dollar credit line draw used for the Hiya deal, ended the quarter debt-free with 151 million dollars in cash and repurchased 528,000 shares for 15 million dollars.